Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

Autor: Masi, Gianluca, Loupakis, Fotios, Salvatore, Lisa, Fornaro, Lorenzo, Cremolini, Chiara, Cupini, Samanta, Ciarlo, Andrea, Del Monte, Francesca, Cortesi, Enrico, Amoroso, Domenico, Granetto, Cristina, Fontanini, Gabriella, Sensi, Elisa, Lupi, Cristiana, Andreuccetti, Michele, Falcone, Alfredo
Zdroj: In The Lancet Oncology September 2010 11(9):845-852
Databáze: ScienceDirect